BurtonF.DickeyMD
Pulmonology • Houston, TXCritical Care Medicine, Pleural Disease
Associate Professor, Pulmonology, Baylor College of Medicine
Are you Dr. Dickey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 84 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Summary
- Dr. Burton Dickey, MD is a pulmonologist in Houston, Texas. He is currently licensed to practice medicine in Texas, Florida, and Massachusetts. He is affiliated with University of Texas M.D. Anderson Cancer Center and is an Associate Professor at Baylor College of Medicine.
Education & Training
Boston University Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1983 - 1986
Temple University HospitalResidency, Internal Medicine, 1980 - 1983
Uconn School Of MedicineClass of 1980
Certifications & Licensure
FL State Medical License 2021 - Present
TX State Medical License 2006 - 2026
MA State Medical License 1983 - 2007
PA State Medical License 1981 - 1984- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Publications & Presentations
PubMed
- 758 citationsA common MUC5B promoter polymorphism and pulmonary fibrosisMax A. Seibold, Anastasia L. Wise, Marcy C. Speer, Mark P. Steele, Kevin K. Brown
The New England Journal of Medicine. 2011-04-21 - 80 citationsRegenerative Metaplastic Clones in COPD Lung Drive Inflammation and Fibrosis.Wei Rao, Shan Wang, Marcin Duleba, Suchan Niroula, Kristina Goller
Cell. 2020-05-14 - 2 citationsInterstitial lung abnormalities after hospitalization for COVID-19 in patients with cancer: A prospective cohort study.Sungryong Noh, Christopher Bertini, Isabel Mira-Avendano, Maryam Kaous, Bela Patel
Cancer Medicine. 2023-09-01
Press Mentions
Here’s Why People with Allergic Asthma Have a Lower COVID-19 RiskMay 2nd, 2022- The Body’s Response to Allergic Asthma Also Helps Protect Against COVID-19May 2nd, 2022
- Groundbreaking Treatment for COPD, Asthma, and Cystic FibrosisMarch 24th, 2022
- Join now to see all
Grant Support
- Mechanisms Of Beta-Blocker Induced Improvements In AsthmaNational Institute Of Allergy And Infectious Diseases2012
- Molecular Pathways Regulating Airway Goblet Cell Mucin SecretionNational Heart, Lung, And Blood Institute2010–2012
- Regulation Of Mucin Exocytosis By Munc18National Heart, Lung, And Blood Institute2009–2010
- Munc18 Proteins In Airway Mucus HypersecretionNational Heart, Lung, And Blood Institute2005–2006
- Munc18 Proteins In Airway Mucus HypersecretionNational Heart, Lung, And Blood Institute2003–2004
- Research Training In Lung DiseaseNational Heart, Lung, And Blood Institute2003
- Control Of Secretion By Small GTP Binding ProteinsNational Heart, Lung, And Blood Institute1999–2002
- Control Of Secretion By Small Gtp-Binding ProteinsNational Heart, Lung, And Blood Institute1993–1996
- Control Of Surfactant Secretion By GTP Binding ProteinsNational Heart, Lung, And Blood Institute1990–1992
- Control Of Surfactant Secretion By GTP Binding ProteinsNational Heart, Lung, And Blood Institute1989–1990
- Lectin Receptors In Slime Molds And Lung CellsNational Heart, Lung, And Blood Institute1985–1989
